全文获取类型
收费全文 | 2453篇 |
免费 | 365篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 107篇 |
妇产科学 | 26篇 |
基础医学 | 161篇 |
口腔科学 | 33篇 |
临床医学 | 447篇 |
内科学 | 645篇 |
皮肤病学 | 62篇 |
神经病学 | 229篇 |
特种医学 | 294篇 |
外科学 | 230篇 |
综合类 | 47篇 |
一般理论 | 3篇 |
预防医学 | 251篇 |
眼科学 | 23篇 |
药学 | 187篇 |
中国医学 | 1篇 |
肿瘤学 | 91篇 |
出版年
2023年 | 56篇 |
2022年 | 17篇 |
2021年 | 35篇 |
2020年 | 94篇 |
2019年 | 23篇 |
2018年 | 95篇 |
2017年 | 80篇 |
2016年 | 73篇 |
2015年 | 69篇 |
2014年 | 109篇 |
2013年 | 137篇 |
2012年 | 80篇 |
2011年 | 80篇 |
2010年 | 106篇 |
2009年 | 141篇 |
2008年 | 89篇 |
2007年 | 98篇 |
2006年 | 84篇 |
2005年 | 84篇 |
2004年 | 54篇 |
2003年 | 33篇 |
2002年 | 43篇 |
2001年 | 49篇 |
2000年 | 39篇 |
1999年 | 41篇 |
1998年 | 90篇 |
1997年 | 100篇 |
1996年 | 83篇 |
1995年 | 74篇 |
1994年 | 54篇 |
1993年 | 57篇 |
1992年 | 42篇 |
1991年 | 23篇 |
1990年 | 37篇 |
1989年 | 65篇 |
1988年 | 56篇 |
1987年 | 35篇 |
1986年 | 33篇 |
1985年 | 28篇 |
1984年 | 21篇 |
1983年 | 15篇 |
1982年 | 18篇 |
1981年 | 22篇 |
1980年 | 19篇 |
1979年 | 15篇 |
1978年 | 14篇 |
1976年 | 12篇 |
1975年 | 11篇 |
1973年 | 13篇 |
1971年 | 16篇 |
排序方式: 共有2857条查询结果,搜索用时 15 毫秒
1.
2.
3.
Marlene L Hauck Susan M LaRue William P Petros Jean M Poulson Daohai Yu Ivan Spasojevic Amy F Pruitt Allison Klein Beth Case Donald E Thrall David Needham Mark W Dewhirst 《Clinical cancer research》2006,12(13):4004-4010
PURPOSE: To determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetic characteristics of doxorubicin encapsulated in a low temperature sensitive liposome (LTSL) when given concurrently with local hyperthermia to canine solid tumors. EXPERIMENTAL DESIGN: Privately owned dogs with solid tumors (carcinomas or sarcomas) were treated. The tumors did not involve bone and were located at sites amenable to local hyperthermia. LTSL-doxorubicin was given (0.7-1.0 mg/kg i.v.) over 30 minutes during local tumor hyperthermia in a standard phase I dose escalation study. Three treatments, given 3 weeks apart, were scheduled. Toxicity was monitored for an additional month. Pharmacokinetics were evaluated during the first treatment cycle. RESULTS: Twenty-one patients were enrolled: 18 with sarcomas and 3 with carcinomas. Grade 4 neutropenia and acute death secondary to liver failure, possibly drug related, were the dose-limiting toxicities. The maximum tolerated dose was 0.93 mg/kg. Other toxicities, with the possible exception of renal damage, were consistent with those observed following free doxorubicin administration. Of the 20 dogs that received > or = 2 doses of LTSL-doxorubicin, 12 had stable disease, and 6 had a partial response to treatment. Pharmacokinetic variables were more similar to those of free doxorubicin than the marketed liposomal product. Tumor drug concentrations at a dose of 1.0 mg/kg averaged 9.12 +/- 6.17 ng/mg tissue. CONCLUSION: LTSL-doxorubicin offers a novel approach to improving drug delivery to solid tumors. It was well tolerated and resulted in favorable response profiles in these patients. Additional evaluation in human patients is warranted. 相似文献
4.
5.
6.
7.
8.
9.
G F Needham R R Pfeiffer G L Engel B S Rutherford D J Allen 《Journal of pharmaceutical sciences》1992,81(10):1012-1014
During the development of a silicone rubber implant for the delivery of estradiol 17-beta some batches of implants made from a certain lot of commercial estradiol inexplicably developed surface crystals of estradiol after several days of storage. An impurity profile was obtained for 28 lots of estradiol by a newly developed HPLC method. One or more impurities may have had a role in the spontaneous crystal growth on the surface of the implants, because the one lot of estradiol that initially had surface crystals on aging produced acceptable implants after multiple recrystallizations. Attempts to isolate suspected impurities for characterization were unsuccessful. During the manufacture of the implants, temperatures sufficient to melt the estradiol (mp, 173-179 degrees C) were used. It was expected that, upon implant cooling, melted impure estradiol would form a thermodynamically more active (i.e., noncrystalline) physical form. This metastable form could have migrated to the implant surface, where ambient conditions favored crystallization. Because melted estradiol of a higher purity tended to crystallize more readily, it was less likely to form a glass upon cooling. The phenomenon of surface crystallization was limited to one lot of estradiol with the highest level of impurities. Data from differential scanning calorimetry studies supported this conclusion. 相似文献
10.
筛检对肝癌死亡率影响的研究 总被引:5,自引:0,他引:5
5581名HBsAg阳性的男性随机分入周期性筛检组(A组,3712人)及对照组(B组,1869人)。A组(19155.4人年)共发生肝癌257例,B组(9785.5人年)为117例,两组的肝癌发生率分别为1342/10万与1196/10万;两组肝癌死亡分别为218与109例,肝癌死亡率分别为1138/10万与1114/10万。两组中Ⅰ期肝癌病例分别为29.6%与6.0%,差异有非常显著性意义。1、3、5年相对生存率A组为23.7%、7.0%、4.0%,B组为9.7%、4.0%、4.1%。用Poisson回归模型拟合显示,在调正年龄、初筛AFP及入列年份后,筛检对于肝癌的相对危险度为0.83,95%CI为0.68~1.03,有较弱的“保护”作用,Cox回归模型拟合结果显示当临床分期未引入模型时,筛检对于肝癌有显著的“保护”作用:危险率为0.6617,95%CI为0.5234~0.8365;而模型经调整后,危险率即接近“1”,95%CI为0.74~1.26。 相似文献